60 related articles for article (PubMed ID: 2351325)
1. RPLP1 Is Up-Regulated in Human Adenomyosis and Endometrial Adenocarcinoma Epithelial Cells and Is Essential for Cell Survival and Migration In Vitro.
Peterson R; Minchella P; Cui W; Graham A; Nothnick WB
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36769010
[TBL] [Abstract][Full Text] [Related]
2. Role of benign ovarian cysts in the development of adenomyosis.
Alam S; Ahmad S; Khan MM; Nasir S; Sharif N; Ziaullah S; Khalid A; Rauf F
Saudi Med J; 2016 Sep; 37(9):963-7. PubMed ID: 27570851
[TBL] [Abstract][Full Text] [Related]
3. Incorporation of Tumor-Free Distance and Other Alternative Ultrasound Biomarkers into a Myometrial Invasion-Based Model Better Predicts Lymph Node Metastasis in Endometrial Cancer: Evidence and Future Prospects.
Liro M; Śniadecki M; Wycinka E; Wojtylak S; Brzeziński M; Jastrzębska J; Wydra D
Diagnostics (Basel); 2022 Oct; 12(11):. PubMed ID: 36359447
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological characteristics and survival outcomes of patients with coexistence of adenomyosis and endometrial carcinoma.
Zhang Z; Yang B; Zhang W; Gao X; Zhao C; Zhang X; Wang L; Zhang Y; Zhang F; Zhang H; Shan B
Int J Clin Exp Pathol; 2018; 11(2):956-962. PubMed ID: 31938189
[TBL] [Abstract][Full Text] [Related]
5. Pathologic Prognostic Factors in Endometrial Carcinoma (Other Than Tumor Type and Grade).
Singh N; Hirschowitz L; Zaino R; Alvarado-Cabrero I; Duggan MA; Ali-Fehmi R; Euscher E; Hecht JL; Horn LC; Ioffe O; Matias-Guiu X; McCluggage WG; Mikami Y; Ordi J; Parkash V; Quddus MR; Quick CM; Staebler A; Zaloudek C; Nucci M; Malpica A; Oliva E
Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S93-S113. PubMed ID: 30550486
[TBL] [Abstract][Full Text] [Related]
6. Coexistence of adenomyosis, adenocarcinoma, endometrial and myometrial lesions in resected uterine specimens.
Tetikkurt S; Çelik E; Taş H; Cay T; Işik S; Usta AT
Mol Clin Oncol; 2018 Aug; 9(2):231-237. PubMed ID: 30101029
[TBL] [Abstract][Full Text] [Related]
7. Reproducibility of measurement of myometrial invasion in endometrial carcinoma.
van der Putten LJ; van de Vijver K; Bartosch C; Davidson B; Gatius S; Matias-Guiu X; McCluggage WG; Toledo G; van der Wurff AA; Pijnenborg JM; Massuger LF; Bulten J
Virchows Arch; 2017 Jan; 470(1):63-68. PubMed ID: 27787595
[TBL] [Abstract][Full Text] [Related]
8. [Pitfalls in the histopathological diagnostics of endometrial carcinoma and its precursors : Clinically relevant differential diagnoses, avoidance of false positive diagnoses].
Kommoss F; Lax SF
Pathologe; 2016 Nov; 37(6):512-520. PubMed ID: 27681950
[TBL] [Abstract][Full Text] [Related]
9. Coexistence of adenomyosis and endometrioid endometrial cancer: Role in surgical guidance and prognosis estimation.
Gizzo S; Patrelli TS; Dall'asta A; DI Gangi S; Giordano G; Migliavacca C; Monica M; Merisio C; Nardelli GB; Quaranta M; Noventa M; Berretta R
Oncol Lett; 2016 Feb; 11(2):1213-1219. PubMed ID: 26893721
[TBL] [Abstract][Full Text] [Related]
10. Endometrioid adenocarcinoma arising in adenomyosis: elucidation by periodic magnetic resonance imaging evaluations.
Motohara K; Tashiro H; Ohtake H; Saito F; Ohba T; Katabuchi H
Int J Clin Oncol; 2008 Jun; 13(3):266-70. PubMed ID: 18553239
[TBL] [Abstract][Full Text] [Related]
11. The role of CD10 staining in distinguishing invasive endometrial adenocarcinoma from adenocarcinoma involving adenomyosis.
Nascimento AF; Hirsch MS; Cviko A; Quade BJ; Nucci MR
Mod Pathol; 2003 Jan; 16(1):22-7. PubMed ID: 12527709
[TBL] [Abstract][Full Text] [Related]
12. Pathology and physiopathology of adenomyosis.
Bergeron C; Amant F; Ferenczy A
Best Pract Res Clin Obstet Gynaecol; 2006 Aug; 20(4):511-21. PubMed ID: 16563870
[TBL] [Abstract][Full Text] [Related]
13. Spectrum of MR features in adenomyosis.
Tamai K; Koyama T; Umeoka S; Saga T; Fujii S; Togashi K
Best Pract Res Clin Obstet Gynaecol; 2006 Aug; 20(4):583-602. PubMed ID: 16564228
[TBL] [Abstract][Full Text] [Related]
14. Endometrial adenocarcinoma with variable-level myometrial involvement limited to adenomyosis: a clinicopathologic study of 23 cases.
Jacques SM; Lawrence WD
Gynecol Oncol; 1990 Jun; 37(3):401-7. PubMed ID: 2351325
[TBL] [Abstract][Full Text] [Related]
15. Adenomyosis is associated with myometrial invasion by FIGO 1 endometrial adenocarcinoma.
Ismiil ND; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Thomas G; Ackerman I; Covens A; Khalifa MA
Int J Gynecol Pathol; 2007 Jul; 26(3):278-83. PubMed ID: 17581412
[TBL] [Abstract][Full Text] [Related]
16. Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion.
Ismiil N; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Ackerman I; Thomas G; Covens A; Khalifa MA
Ann Diagn Pathol; 2007 Aug; 11(4):252-7. PubMed ID: 17630108
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]